|
| |
| | | 52656 | | 16.05.1994 | | Novartis Pharma Schweiz AG | | 15.09.2004 | | | | | | | | | | | 07.15. | | | | 07.15. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Sandimmun Neoral 25 mg | Kapseln | Capsules (Cyclosporine 25 mg) | L04AD01 | CI | | 02 | Sandimmun Neoral 50 mg | Kapseln | Capsules (Cyclosporine 50 mg) | L04AD01 | CI | | 03 | Sandimmun Neoral 100 mg | Kapseln | Capsules (Cyclosporine 100 mg) | L04AD01 | CI | | 04 | Sandimmun Neoral 10 mg | Kapseln | Capsules (Cyclosporine 10 mg) | L04AD01 | CI |
|
|
|
